ClinicalTrials.gg
CompletedNCT07205848Updated Oct 3, 2025

Evaluating Public Awareness and Preventive Actions for Dengue Fever in Sudan Amidst Ongoing Crises

An observational study in Dengue Hemorrhagic Fever and Awareness, sponsored by Research and Publication office. Completed at 1 site in Sudan. Open to participants aged 17 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2025-10-03.

Sponsored by Research and Publication office · Observational

Study type
Observational
Model
Other
Time perspective
Cross-sectional
Enrollment
164
Ages
17 Years and older
Sex
All
01

Study summary

This study evaluates the awareness of dengue fever and preventive measures among Sudanese people during the war. It assesses knowledge, awareness, implementation of prevention, access to healthcare, community involvement, and the link between knowledge and practice. The findings aim to enhance disease control strategies in conflict settings.

Read the detailed description

This study aims to evaluate the level of awareness of dengue fever and preventive measures among the Sudanese population during the war. The research focuses on understanding public knowledge, awareness, and the implementation of preventive actions in a conflict setting, aligning with various Sustainable Development Goals (SDGs).

The specific objectives include:

  1. Measuring the knowledge level of the Sudanese population regarding dengue fever during the war (SDG 3, 4).
  2. Evaluating awareness of preventive measures against dengue fever (SDG 3, 6).
  3. Assessing the extent to which preventive measures are implemented (SDG 3, 11).
  4. Investigating access to healthcare facilities during the dengue fever outbreak (SDG 3, 10).
  5. Identifying the role of community participation in controlling the outbreak (SDG 3, 17).
  6. Examining the correlation between knowledge levels and the implementation of preventive measures (SDG 3).

By addressing these objectives, the study aims to provide insights into public health challenges and community responses during the war, contributing to improved disease control strategies in conflict-affected areas

02

Conditions studied

  • Dengue Hemorrhagic Fever
  • Awareness

Keywords

  • Dengue Fever
  • Sudan
  • Awareness
  • Prevention
  • Public
03

In context

Severe Dengue

65 studies on the registry are indexed under Severe Dengue; 5 are open to participants now.

This study's enrollment of 164 is below the median of 667 across 13 observational studies indexed under Severe Dengue.

Browse Severe Dengue studies →

Lead sponsor

Research and Publication office is the lead sponsor of 5 studies on the registry; none are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
17 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes
Sampling method
Non-probability sample

Study population

Sudanese individuals above or equal 17 years and above residing in any part of

Eligibility criteria

- Inclusion Criteria: Sudanese nationals with internet access Residents in any part of Sudan age above or equal 17 years Individuals willing to participate

- Exclusion Criteria: Non Sudanese nationals. Sudanese nationals with no internet access Residence outside Sudan age less than 17 years

05

Study design

Observational model
Other
Time perspective
Cross-sectional
Enrollment
164 participants (actual)
Patient registry
No

Groups and cohorts

  • Sudanese nationals with internet access

    Sudanese nationals with internet access

    Other: No intervention

Interventions

  • OtherNo intervention

    No intervention

06

What researchers measure

Primary outcomes

  1. Primary Outcomes: Level of Knowledge: Percentage of the Sudanese population aware of dengue fever and its symptoms during the war

    Using a structured, self-administered questionnaire (SAQ) based on a validated KAP survey on dengue fever.

    Time frame: 1_2 months

Secondary outcomes

  1. To measure the preventive knowledge against dengue fever

    Using a structured, self-administered questionnaire (SAQ) based on a validated KAP survey on dengue fever, in the form of (True, False, I don't know) responses.

    Time frame: Jan - Mar 2025

  2. to measure the extent of implementation of preventive measures.

    Using a structured, self-administered questionnaire (SAQ) based on a validated KAP survey on dengue fever, in the form of Likert's scale responses.

    Time frame: 1- 2 months

07

Study locations

1 site
  • Research and publication office
    Khartoum, Omdurman 11111, Sudan
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Ran from Jan 2025 to primary completion in Mar 2025, 2 months.

How these figures are worked out, and which studies are left out of them.

Registered
Feb 10, 2025
First posted
Oct 3, 2025
StartActual
Jan 1, 2025
Primary completionActual
Mar 1, 2025
CompletionActual
Mar 1, 2025
Last update
Oct 3, 2025
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Oct 3, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07205848
Lead sponsor
Research and Publication office
Responsible party
Sponsor
First posted
Oct 3, 2025
Start date
Jan 1, 2025
Primary completion
Mar 1, 2025
Completion
Mar 1, 2025
Last update
Oct 3, 2025

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Dec 2024. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion